GET THE APP

Cardiovascular Risk Determined by Genetic Polymorphisms and Epigenetics

International Journal of Cardiovascular Research.ISSN: 2324-8602

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Cardiovascular Risk Determined by Genetic Polymorphisms and Epigenetics

Several risk factors for the development of cardiovascular disorders, such dyslipidemias, can trigger phenomena such as atherosclerosis, coronary disease and even infarction. The adoption of healthy lifestyle habits such a low calorie diet with low cholesterol content, rich in unsaturated fatty acids, fibers and antioxidants such as flavonoids and omega-3, abandonment of alcohol and tobacco and physical exercise are some of the most recommended approaches to decrease serum cholesterol and triglyceride concentrations, as well as increase the liver production of High Density Lipoprotein (HDL). However, for some patients, even maintaining a healthy lifestyle, serum lipids levels remain higher than those considered safe, being refractory to conventional treatments with statins, fibrates, sequestering resins, and inhibitors of intestinal cholesterol absorption, for example. In these cases, it has been suggested the involvement of genotypic conditions, both genetic polymorphism or epigenetics, being necessary more specific diagnostic and management designs. Thus, the present editorial for the International Journal of Cardiovascular Research aims to reinforce this area of knowledge, encourage researchers to invest in works focused on this theme and describe a theoretical framework to be considered in clinical practice.

Special Features

Full Text

View

Track Your Manuscript

Media Partners

Associations